Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)
NCT ID: NCT03816202
Last Updated: 2022-01-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2019-04-25
2019-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-Centering Guide Catheter Feasibility Study
NCT02639494
Study on the Trans-Carotid Artery Occlusion Shunt System Combined With Introducer Sets
NCT06959628
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
NCT00600327
Study on the Trans-Carotid Artery Occlusion Shunt System Combined With Introducer Sets
NCT06864299
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy
NCT03606642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sundt Carotid Shunt
Subject has undergone a endarterectomy procedure with the use of the Sundt Carotid Shunt.
Sundt carotid shunt
The Integra Sundt™ carotid shunts are indicated for temporary carotid artery bypass during carotid endarterectomy procedures to help protect the cerebral hemispheres from ischemia during the period of carotid artery occlusion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sundt carotid shunt
The Integra Sundt™ carotid shunts are indicated for temporary carotid artery bypass during carotid endarterectomy procedures to help protect the cerebral hemispheres from ischemia during the period of carotid artery occlusion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have undergone carotid endarterectomy with any Integra Sundt™ carotid shunt on or before date of study initiation
* Availability of records on post-operative imaging of the carotid artery either by carotid duplex ultrasound or angiogram
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Integra LifeSciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Tummon
Role: STUDY_DIRECTOR
Integra LifeSciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Institute of Deaconess Clinic
Newburgh, Indiana, United States
Hackensack Meridian Health
Hackensack, New Jersey, United States
The Mount Sinai Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-SCS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.